Cargando…
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Osteoclasts are specialised bone resorbing cells that control both physiological and pathological bone turnover. Functional changes in the differentiation and activity of osteoclasts are accompanied by active metabolic reprogramming. However, the biological significance and the in vivo relevance of...
Autores principales: | Taubmann, Jule, Krishnacoumar, Brenda, Böhm, Christina, Faas, Maria, Müller, Dorothea I. H., Adam, Susanne, Stoll, Cornelia, Böttcher, Martin, Mougiakakos, Dimitrios, Sonnewald, Uwe, Hofmann, Jörg, Schett, Georg, Krönke, Gerhard, Scholtysek, Carina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713370/ https://www.ncbi.nlm.nih.gov/pubmed/33273570 http://dx.doi.org/10.1038/s41598-020-77892-4 |
Ejemplares similares
-
PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass
por: Müller, Dorothea I. H., et al.
Publicado: (2020) -
Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss
por: Lucas, Sébastien, et al.
Publicado: (2018) -
Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas
por: Böttcher, Martin, et al.
Publicado: (2020) -
The role of MicroRNAs in Osteoclasts and Osteoporosis
por: Tang, Peifu, et al.
Publicado: (2015) -
Membrane trafficking in osteoclasts and implications for osteoporosis
por: Ng, Pei Ying, et al.
Publicado: (2019)